Enanta Pharmaceuticals's total assets for Q2 2026 were $314.70M, a decrease of -4.49% from the previous quarter. ENTA total liabilities were $198.12M for the fiscal quarter, a -2.36% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.